66495-1-Ig

antibody from Proteintech Group

Targeting: BIRC5 API4, EPR-1, survivin

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Flow cytometry (Data presented on provider website)

Antibody Data

Product number

66495-1-Ig

Provider

Proteintech Group

Product name

SURVIVIN antibody

Antibody type

Monoclonal

Description

KD/KO validated SURVIVIN antibody (Cat. #66495-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: FC, WB,ELISA.

Reactivity

Human

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

3B9H7

Vial size

20ul, 150ul

References

Submitted references

Astragaloside Ⅳ negatively regulates Gpr97-TPL2 signaling to protect against hyperhomocysteine-exacerbated sepsis associated acute kidney injury.

Xu J, Zhang Z, Ren D, Liu L, Xing H, Wang D, Wu Y, Zhang Y, Chen Q, Wang T
Phytomedicine : international journal of phytotherapy and phytopharmacology 2024 Mar;125:155346

---

Study on the mechanism of S100A4-mediated cancer oncogenesis in uveal melanoma cells through the integration of bioinformatics and in vitro experiments.

Chen H, Zhang W, Shi J, Tang Y, Chen X, Li J, Yao X
Gene 2024 Jun 15;911:148333

---

The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells.

Galiger C, Zohora FT, Dorneburg C, Tews D, Debatin KM, Beltinger C
BMC cancer 2023 Nov 25;23(1):1148

---

Analysis of regulating activities of 5'-epiequisetin on proliferation, apoptosis, and migration of prostate cancer cells in vitro and in vivo.

Wang X, Luo X, Gan X, Chen C, Yang Z, Wen J, Fang W, Huang H, Gao C, Zhou X, Feng X, Liu Y
Frontiers in pharmacology 2022;13:920554

---

Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the Serpinc1 gene.

Zhang J, Tang Z, Guo X, Wang Y, Zhou Y, Cai W
Frontiers in oncology 2022;12:933646

---

Multistage targeting and dual inhibiting strategies based on bioengineered tumor matrix microenvironment-mediated protein nanocages for enhancing cancer biotherapy.

Hu F, Deng C, Zhou Y, Liu Y, Zhang T, Zhang P, Zhao Z, Miao H, Zheng W, Zhang W, Wang M, Ma X
Bioengineering & translational medicine 2022 May;7(2):e10290

---

m(6)A-mediated upregulation of AC008 promotes osteoarthritis progression through the miR-328-3p‒AQP1/ANKH axis.

Yang J, Zhang M, Yang D, Ma Y, Tang Y, Xing M, Li L, Chen L, Jin Y, Ma C
Experimental & molecular medicine 2021 Nov;53(11):1723-1734

---

Proliferation inhibition and apoptosis promotion by dual silencing of VEGF and Survivin in human osteosarcoma.

Gu J, Ji Z, Li D, Dong Q
Acta biochimica et biophysica Sinica 2019 Jan 1;51(1):59-67